We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Gil Y. Melmed, MD

Director, Clinical Inflammatory Bowel Disease

Director, Advanced Inflammatory Bowel Disease Fellowship Program

Director, Clinical Research in the Division of Gastroenterology

8730 Alden Drive
Steven Spielberg Building, Suite 2-East
Los Angeles, CA 90048

Phone:

310-423-4100

Fax:

310-423-0146

Gil Y. Melmed, MD

Director, Clinical Inflammatory Bowel Disease

Director, Advanced Inflammatory Bowel Disease Fellowship Program

Director, Clinical Research in the Division of Gastroenterology

  • IM/Gastroenterology

Capsule Endoscopy

Colonoscopy

Crohn's Disease

Esophageal Disorders

Gastrointestinal Disorders

Inflammatory Bowel Disease (IBD)

Ulcerative Colitis

Upper Gastrointestinal Endoscopy

The research of Gil Melmed, MD, focuses on clinical outcomes research in inflammatory bowel disease. Specifically, he is interested in vaccine-preventable illnesses, disease phenotype and classification, post-operative outcomes, disease activity assessment and health-related quality of life.

  • Residency: Cedars-Sinai, 2003
  • Fellowship: Cedars-Sinai, 2006
  • Section Editor: Inflammatory Bowel Disease, 2009-10
  • Crohn's and Colitis Foundation of America, 2007
  • American College of Gastroenterology, 2005
  • American Gastroenterology Association, 2002
  • Melmed GY, Agarwal N, Frenck RW, Ippoliti AF, Ibanez P, Papadakis KA, Simpson P, Barolet-Garcia C, Ward J, Targan SR, Vasiliauskas EA. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2009;105(1):148-154.
  • Melmed GY, Elashoff R, Chen GC, Nastaskin I, Papadakis KA, Vasiliauskas EA, Liu W, Landers C, Ippoliti AF, Targan SR. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study. Clin Gastroenterol Hepatol. 2007;5(5):602-608.
  • Melmed GY, Fleshner PR, Bardakcioglu O, Ippoliti A, Vasiliauskas EA, Papadakis KA, Dubinsky M, Landers C, Rotter JI, Targan SR. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2007;51(1):100-108.
  • Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101(8):1834-1840.
  • Melmed GY, Targan SR. Future biologic targets for IBD: potentials and pitfalls. Nat Rev Gastroenterol Hepatol. 2010;7(2):110-117.
  • Spiegel BM, Ho W, Esrailian E, Targan S, Higgins PD, Siegel CA, Dubinsky M, Melmed GY. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol. 2008;7(2):168-174.

Show moreShow less

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Send Email to Gil Y. Melmed, MD